GB0220913D0 - Medical treatment - Google Patents

Medical treatment

Info

Publication number
GB0220913D0
GB0220913D0 GB0220913A GB0220913A GB0220913D0 GB 0220913 D0 GB0220913 D0 GB 0220913D0 GB 0220913 A GB0220913 A GB 0220913A GB 0220913 A GB0220913 A GB 0220913A GB 0220913 D0 GB0220913 D0 GB 0220913D0
Authority
GB
United Kingdom
Prior art keywords
medical treatment
medical
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0220913A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celldex Therapeutics Ltd
Original Assignee
Lorantis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB0220913A priority Critical patent/GB0220913D0/en
Application filed by Lorantis Ltd filed Critical Lorantis Ltd
Publication of GB0220913D0 publication Critical patent/GB0220913D0/en
Priority to AU2002339157A priority patent/AU2002339157A1/en
Priority to PCT/GB2002/005137 priority patent/WO2003041735A2/en
Priority to PCT/GB2002/005133 priority patent/WO2003042246A2/en
Priority to CA002465304A priority patent/CA2465304A1/en
Priority to JP2003543622A priority patent/JP2005518785A/en
Priority to JP2003544081A priority patent/JP2005526701A/en
Priority to EP02779679A priority patent/EP1446424A2/en
Priority to EP02777532A priority patent/EP1448599A2/en
Priority to JP2003584114A priority patent/JP2006506322A/en
Priority to EP03746366A priority patent/EP1492816A2/en
Priority to AU2003226537A priority patent/AU2003226537A1/en
Priority to PCT/GB2003/001525 priority patent/WO2003087159A2/en
Priority to AU2003255735A priority patent/AU2003255735A1/en
Priority to PCT/GB2003/003285 priority patent/WO2004013179A1/en
Priority to JP2005506075A priority patent/JP2006513260A/en
Priority to EP03766445A priority patent/EP1525221A1/en
Priority to CA002497226A priority patent/CA2497226A1/en
Priority to AU2003267563A priority patent/AU2003267563A1/en
Priority to PCT/GB2003/003908 priority patent/WO2004024764A1/en
Priority to JP2004571915A priority patent/JP2006515177A/en
Priority to EP03748255A priority patent/EP1537145A1/en
Priority to US10/845,834 priority patent/US20050137130A1/en
Priority to US10/846,989 priority patent/US20050026831A1/en
Priority to US10/958,784 priority patent/US20050220886A1/en
Priority to US11/050,346 priority patent/US20060002924A1/en
Priority to US11/078,735 priority patent/US20050261477A1/en
Ceased legal-status Critical Current

Links

GB0220913A 2001-11-14 2002-09-10 Medical treatment Ceased GB0220913D0 (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
GB0220913A GB0220913D0 (en) 2002-09-10 2002-09-10 Medical treatment
EP02777532A EP1448599A2 (en) 2001-11-14 2002-11-13 Inhibitors of the notch signalling pathway for use in the treatment of cancer
CA002465304A CA2465304A1 (en) 2001-11-14 2002-11-13 Composition comprising inhibitors of the notch signalling pathway for the modulation of the immune system
PCT/GB2002/005137 WO2003041735A2 (en) 2001-11-14 2002-11-13 Composotion comprising inhibitors of the notch signalling pathway for the modulation of the immune system
PCT/GB2002/005133 WO2003042246A2 (en) 2001-11-14 2002-11-13 Inhibitors of the notch signalling pathway for use in the treatment of cancer
AU2002339157A AU2002339157A1 (en) 2001-11-14 2002-11-13 Inhibitors of the notch signalling pathway for use in the treatment of cancer
JP2003543622A JP2005518785A (en) 2001-11-14 2002-11-13 Internal medicine
JP2003544081A JP2005526701A (en) 2001-11-14 2002-11-13 Internal medicine
EP02779679A EP1446424A2 (en) 2001-11-14 2002-11-13 Composition comprising inhibitors of the notch signalling pathway for the modulation of the immune system
JP2003584114A JP2006506322A (en) 2002-04-05 2003-04-04 Internal medicine
EP03746366A EP1492816A2 (en) 2002-04-05 2003-04-04 Modulators of the notch signalling pathway and uses thereof in medical treatment
AU2003226537A AU2003226537A1 (en) 2002-04-05 2003-04-04 Modulators of the notch signalling pathway and uses thereof in medical treatment
PCT/GB2003/001525 WO2003087159A2 (en) 2002-04-05 2003-04-04 Modulators of the notch signalling pathway and uses thereof in medical treatment
AU2003255735A AU2003255735A1 (en) 2002-08-03 2003-08-01 Conjugate of notch signalling pathway modulators and their use in medical treatment
EP03766445A EP1525221A1 (en) 2002-08-03 2003-08-01 Conjugate of notch signalling pathway modulators and their use in medical treatment
PCT/GB2003/003285 WO2004013179A1 (en) 2002-08-03 2003-08-01 Conjugate of notch signalling pathway modulators and their use in medical treatment
JP2005506075A JP2006513260A (en) 2002-08-03 2003-08-01 Complexes of Notch signaling pathway regulators and their use in drug therapy
EP03748255A EP1537145A1 (en) 2002-09-10 2003-09-09 Pharmaceutical compositions and medical treatments comprising notch ligand proteins
JP2004571915A JP2006515177A (en) 2002-09-10 2003-09-09 Pharmaceutical composition comprising Notch ligand protein and medical treatment
AU2003267563A AU2003267563A1 (en) 2002-09-10 2003-09-09 Pharmaceutical composition and medical treatments comprising notch ligand proteins
PCT/GB2003/003908 WO2004024764A1 (en) 2002-09-10 2003-09-09 Pharmaceutical composition and medical treatments comprising notch ligand proteins
CA002497226A CA2497226A1 (en) 2002-09-10 2003-09-09 Pharmaceutical compositions and medical treatments comprising notch ligand proteins
US10/845,834 US20050137130A1 (en) 2001-11-14 2004-05-14 Medical treatment
US10/846,989 US20050026831A1 (en) 2001-11-14 2004-05-14 Medical treatment
US10/958,784 US20050220886A1 (en) 2002-04-05 2004-10-05 Modulators of the Notch signalling pathway and uses thereof in medical treatment
US11/050,346 US20060002924A1 (en) 2002-08-03 2005-02-03 Conjugate of notch signalling pathway modulators and their use in medical treatment
US11/078,735 US20050261477A1 (en) 2002-09-10 2005-03-10 Pharmaceutical compositions and medical treatments comprising notch ligand proteins

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0220913A GB0220913D0 (en) 2002-09-10 2002-09-10 Medical treatment

Publications (1)

Publication Number Publication Date
GB0220913D0 true GB0220913D0 (en) 2002-10-23

Family

ID=9943751

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0220913A Ceased GB0220913D0 (en) 2001-11-14 2002-09-10 Medical treatment

Country Status (1)

Country Link
GB (1) GB0220913D0 (en)

Similar Documents

Publication Publication Date Title
GB0201850D0 (en) Therapeutic treatment
GB0216321D0 (en) Therapeutic treatment
GB0201674D0 (en) Medical treatment
HK1078784A1 (en) Therapeutic treatment
GB0218879D0 (en) Medical treatment
GB0223367D0 (en) Therapeutic treatment
GB0210464D0 (en) Therapeutic treatment
GB0300428D0 (en) Medical treatment
GB0307472D0 (en) Medical treatment
GB0306165D0 (en) Medical treatment
GB0223405D0 (en) Medical treatment
GB0224353D0 (en) Medical treatment
GB0227865D0 (en) Medical Treatment
GB0223528D0 (en) Medical treatment
GB0223409D0 (en) Medical treatment
GB0220913D0 (en) Medical treatment
GB0220912D0 (en) Medical treatment
GB0220849D0 (en) Medical treatment
GB0218068D0 (en) Medical treatment
GB0211515D0 (en) Blood treatment
GB0301519D0 (en) Medical treatment
GB0306626D0 (en) Medical treatment
GB0301515D0 (en) Medical treatment
GB0301521D0 (en) Medical treatment
GB0301522D0 (en) Medical treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)